Fentanyl Buccal Tablet
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract▴ The fentanyl buccal tablet (FBT) is a new formulation of fentanyl that uses an effervescent drug delivery system to…
BACKGROUND:Current clinical guidelines have identified the need for studies comparing the effect of different short-acting or…
This study assessed the long‐term safety and tolerability of fentanyl buccal tablet (FBT) in opioid‐tolerant patients with cancer…
Fentanyl buccal tablet (FBT) is a new opioid formulation providing rapid-onset analgesia for the treatment of breakthrough pain…
This study assessed the absolute and relative bioavailabilities and transmucosal and gastrointestinal absorbency of fentanyl…
ABSTRACT Background: Short-acting opioids are commonly used to treat breakthrough pain (BTP) and rapid-onset formulations are…
AbstractBackground and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop…
ObjectivesCancer-related breakthrough pain (BTP) is typically managed with a short-acting oral opioid, taken as needed during a…
BackgroundThe fentanyl buccal tablet (FBT) is designed to enhance the rate and extent of fentanyl absorption through the buccal…